Foxy-5 |
| Catalog No.GC36073 |
WNT5A 작용제인 Foxy-5는 Wnt 계열의 비정규 구성원인 WNT5A의 모방 펩티드입니다. Foxy-5는 β-카테닌 활성화에 영향을 미치지 않으면서 세포질 유리 칼슘 신호를 유발하고 상피암 세포의 이동 및 침입을 손상시킵니다. Foxy-5는 동소 마우스 모델에서 WNT5A가 낮은 전립선암 세포의 전이성 확산을 효과적으로 감소시킵니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 881188-51-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Foxy-5 is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 is a WNT5A agonist and effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1][2]. WNT5A[1]
Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1].Foxy-5 reduces the number of colonic cancer stem cells in a xenograft mouse model of human colonic cancer[2].
[1]. Canesin G, et al. Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. PLoS One. 2017 Sep 8;12(9):e0184418. [2]. Osman J, et al. The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. Anticancer Res. 2019 Apr;39(4):1719-1728.
Average Rating: 5 (Based on Reviews and 14 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *